Cargando…
CD4(+)CD25(+)FOXP3(+) Regulatory T Cells Suppress Anti-Tumor Immune Responses in Patients with Colorectal Cancer
BACKGROUND: A wealth of evidence obtained using mouse models indicates that CD4(+)CD25(+)FOXP3(+) regulatory T cells (Treg) maintain peripheral tolerance to self-antigens and also inhibit anti-tumor immune responses. To date there is limited information about CD4(+) T cell responses in patients with...
Autores principales: | Clarke, Sarah L., Betts, Gareth J., Plant, Andrea, Wright, Kate L., El-Shanawany, Tariq M., Harrop, Richard, Torkington, Jared, Rees, Brian I., Williams, Geraint T., Gallimore, Awen M., Godkin, Andrew J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1762416/ https://www.ncbi.nlm.nih.gov/pubmed/17205133 http://dx.doi.org/10.1371/journal.pone.0000129 |
Ejemplares similares
-
Suppression of tumour-specific CD4(+) T cells by regulatory T cells is associated with progression of human colorectal cancer
por: Betts, Gareth, et al.
Publicado: (2011) -
Regulatory T cells inhibit Fas ligand-induced innate and adaptive tumour immunity
por: Simon, Anna Katharina, et al.
Publicado: (2007) -
Hunting for clues: Regulatory T cells and colorectal cancer
por: Gallimore, Awen, et al.
Publicado: (2012) -
A distinct chemokine axis does not account for enrichment of Foxp3(+) CD4(+) T cells in carcinogen-induced fibrosarcomas
por: Ondondo, Beatrice, et al.
Publicado: (2015) -
Interleukin-6 Is Crucial for Recall of Influenza-Specific Memory CD4(+) T Cells
por: Longhi, Maria Paula, et al.
Publicado: (2008)